Tango Therapeutics

+$0.26 (+4.63%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TNGX and other ETFs, options, and stocks.

About TNGX

Tango Therapeutics, Inc. operates as a biotechnology company, which engages in discovering and delivering precision cancer medicines. Its primary program is TNG908, a protein arginine methyl transferase 5 inhibitor that is being developed as a treatment for cancers with MTAP deletions.

CEO
Barbara L. Weber
Employees
91
Headquarters
Cambridge, Massachusetts
Founded
2017

TNGX Key Statistics

Market cap
516.84M
Price-Earnings ratio
—
Dividend yield
—
Average volume
287.20K
High today
$5.97
Low today
$5.63
Open price
$5.65
Volume
290.35K
52 Week high
$18.84
52 Week low
$4.41

TNGX Earnings

-$0.29
-$0.19
-$0.10
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 10, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure